Medical/Pharmaceuticals

Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026

DUBAI, UAE, Jan. 23, 2026 /PRNewswire/ -- Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution atWHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58). Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," Ozelle will highlight how dia...

2026-01-23 18:00 1313

Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation

SHENZHEN, China, Jan. 22, 2026 /PRNewswire/ -- May Li, Board Secretary of Mindray Medical (300760.SZ), delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference (JPM Conference) on January 15, 2026, outlining the company's strategic vision for the next decade centered on three core...

2026-01-22 22:11 4139

pixelRo to Showcase AI-Powered Digital Healthcare and Air Sterilization Solutions at CES 2026 and WHX Dubai

SEOUL, South Korea, Jan. 22. 2026 /PRNewswire/ -- pixelRo, a Samsung Electronics spin-off digital healthcare company, is accelerating its global expansion by participating in CES 2026 and WHX Dubai 2026 (formerly Arab Health). pixelRo develops and operates AI-based integrated self-diagnostic kio...

2026-01-22 16:59 2649

BTL Announces Successful Enforcement of Patent Rights Relating to EMFACE® Against WonderFace Device

PRAGUE, Jan. 22, 2026 /PRNewswire/ -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. ("Lexter"), the manufacturer of the WonderFace device. The settl...

2026-01-22 16:00 1403

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

* Positioning Telangana among the world's top five life sciences clusters by 2030 * Targets USD 25 billion in investments * Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ -- The Government of Telangana, India tod...

2026-01-22 09:00 2080

TraceLink Marks Five Years of Sustained Global Impact Through Corporate Grant Program

From pandemic response to long-term community investment, TraceLink's corporate grants have supported 60 nonprofit organizations worldwide Summary From 2020 through 2025, TraceLink's corporate grant program supported 60 nonprofit organizations worldwide, advancing healthcare access, food security...

2026-01-21 23:00 1838

Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System

Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 /PRNewswire/ -- Trisol Medical, a clinical-stage medical device company developing a ...

2026-01-21 21:55 3834

DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation

WASHINGTON, Jan. 21, 2026 /PRNewswire/ -- The Drug Information Association (DIA) today announced the launch ofDIA ASCENT , a new global platform designed to support early-stag...

2026-01-21 21:39 3330

Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology

* Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines TORONTO, Jan. 21, 2026 /PRNewswire/ -- Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters ...

2026-01-21 21:00 2862

Sisram Medical Partners with Sinmait Medical Technology to Build Next-Generation Manufacturing and Innovation Hub in China

HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced th...

2026-01-21 19:08 2679

HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services

SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research institute focused on conducting clinical trials in hepatology a...

2026-01-21 11:00 2369

CLEARLAB CONTACT LENSES AND LENS CARE PRODUCTS RECEIVE COMBINED MDSAP, ISO13485 AND EU MDR CERTIFICATION FROM DNV

Parallel audit streamlines certification and speeds up access to global markets SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- DNV, the independent global assurance and risk management provider, has certified contact lenses and multi-purpose lens care solutions from Clearlab in accordance with the Medi...

2026-01-21 10:00 2598

Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.

IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions , a global biotechnology company, andPangea Laboratory

2026-01-21 09:00 3322

Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy

* Japan's Ministry of Health, Labour and Welfare (MHLW) grants MCO-010 Sakigake (Pioneering Regenerative Medical Product) and Orphan Drug designations, enabling an accelerated regulatory pathway for patients with severe inherited retinal diseases * Enhances strong global regulatory momentum, ...

2026-01-21 06:00 2615

Baxter's Room Temperature HEMOPATCH Sealing Hemostat Gains Momentum in Australia and New Zealand

DEERFIELD, Ill., Jan. 21, 2026 /PRNewswire/ -- Baxter Healthcare is pleased to share the growing success of the room temperature storage configuration of Hemopatch Sealing Hemostat, launched earlier, this Summer, across Australia and New Zealand. Since its introduction, the product has been met w...

2026-01-21 03:00 2200

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

BENGALURU, India, Jan. 21, 2026 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broaden...

2026-01-21 01:55 1795

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product,strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more LOS ANGELES and MELBOURNE, Australia, Jan. 20, 2026 /PRNewswire/ -- 4DMedical, the lead...

2026-01-20 19:00 3429

Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous (SQ) dosing in humans. - ASC37's average in vitro activity was approximately 5-, 4-, and 4-fold more potent t...

2026-01-20 17:00 2612

Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides an update on its commercial and operational performance for the quarter ended 31 December 2025 (Q4 2025). Q4 2025 Highlights * Full-year (FY) 2...

2026-01-20 15:16 4021

cpThrive: A first-of-its-kind digital guide to help identify evidence-based cerebral palsy treatments

SYDNEY, Jan. 20, 2026 /PRNewswire/ -- Cerebral Palsy Alliance, The University of Sydney, and CSIRO, Australia's national science agency, have commissioned Miroma Project Factory to deliver a groundbreaking mobile app that helps people with cerebral palsy (CP), their carers, and clinicians underst...

2026-01-20 13:46 2402
12345 ... 396

Week's Top Stories